Biotech Growth: we will ride out this storm
Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.
Sector Spotlight: Kleinwort Benson's Choukeir on UK equities
In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.
Picton: the UK property hotspots for rental income
Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.
Brewin's Foster talks financial crisis MkII with Allianz's Riddell
This week Brewin Dolphin's head of research talks to Mike Riddell, fund manager at Allianz Global Investors, about the forces driving bonds markets in a tumultuous week for markets.
Henderson's Hermon: how to be defensive in smaller caps
Hermon, who manages the Henderson Smaller Companies trust, talks about he will tackle a 'challenging' 2016.
Kames' bond chief Roberts: 'Fixed income will not fall apart'
Kames Capital head of fixed income David Roberts expects steady, if unspectacular, returns from bonds in 2016 and refutes the naysayers' concerns that the asset class could 'fall apart'.
AA-rated Weindling: banking on a Japanese tourist boon
Nicholas Weindling, co-manager of the JPMorgan Japanese Investment Trust, explains how to find opportunities in an ailing economy.
Taxicab Tenner: Xmas special
As 2015 draws to a close, Wealth Manager's Jon Yarker takes a look back at a year of backseat interviews.
Kames' Stephen Jones: gentle Fed
Investors should not fret about the Federal Reserve's decision to lift interest rates yesterday, as it points to 'gently better times to come', says Kames Capital CIO Stephen Jones.
Mercantile's Anderson: why I'm 'very positive' on UK stocks
Guy Anderson, manager of the £2.16 billion Mercantile Investment Trust looks forward to next year.
Esma index tracker probe is ‘unactionable’ and ‘illogical’
A European Securities and Markets Authority (Esma) report claiming as many as one in seven funds are closet trackers has been welcomed by wealth managers but also described as ‘unactionable’.
Fund buy list dilemma: venturing off the beaten track
Is the grass greener on the other side for wealth managers sticking to their buy lists?
Why are banks getting such a battering?
The huge sell-off in bank shares since the New Year is driven by fears that we could be heading for a Japan-like depression.